These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 16369535)

  • 1. Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma.
    Mathas S; Janz M; Hummel F; Hummel M; Wollert-Wulf B; Lusatis S; Anagnostopoulos I; Lietz A; Sigvardsson M; Jundt F; Jöhrens K; Bommert K; Stein H; Dörken B
    Nat Immunol; 2006 Feb; 7(2):207-15. PubMed ID: 16369535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrant expression of ID2, a suppressor of B-cell-specific gene expression, in Hodgkin's lymphoma.
    Renné C; Martin-Subero JI; Eickernjäger M; Hansmann ML; Küppers R; Siebert R; Bräuninger A
    Am J Pathol; 2006 Aug; 169(2):655-64. PubMed ID: 16877363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reprogramming of B lymphoid cells in human lymphoma pathogenesis.
    Janz M; Dörken B; Mathas S
    Cell Cycle; 2006 May; 5(10):1057-61. PubMed ID: 16687930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of bHLH transcription factor E2A activity in primary effusion lymphoma confers resistance to apoptosis.
    Lietz A; Janz M; Sigvardsson M; Jundt F; Dörken B; Mathas S
    Br J Haematol; 2007 May; 137(4):342-8. PubMed ID: 17456056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant expression of Notch1 interferes with the B-lymphoid phenotype of neoplastic B cells in classical Hodgkin lymphoma.
    Jundt F; Acikgöz O; Kwon SH; Schwarzer R; Anagnostopoulos I; Wiesner B; Mathas S; Hummel M; Stein H; Reichardt HM; Dörken B
    Leukemia; 2008 Aug; 22(8):1587-94. PubMed ID: 18449208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The helix-loop-helix protein Id2 is expressed differentially and induced by myc in T-cell lymphomas.
    Cotta CV; Leventaki V; Atsaves V; Vidaki A; Schlette E; Jones D; Medeiros LJ; Rassidakis GZ
    Cancer; 2008 Feb; 112(3):552-61. PubMed ID: 18085637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Instructive role of the transcription factor E2A in early B lymphopoiesis and germinal center B cell development.
    Kwon K; Hutter C; Sun Q; Bilic I; Cobaleda C; Malin S; Busslinger M
    Immunity; 2008 Jun; 28(6):751-62. PubMed ID: 18538592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reprogramming of the tumour B-cell phenotype in Hodgkin lymphoma.
    Küppers R; Bräuninger A
    Trends Immunol; 2006 May; 27(5):203-5. PubMed ID: 16563865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repression of TCF3/E2A contributes to Hodgkin lymphomagenesis.
    Guan H; Xie L; Wirth T; Ushmorov A
    Oncotarget; 2016 Jun; 7(24):36854-36864. PubMed ID: 27166193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ID helix-loop-helix proteins as determinants of cell survival in B-cell chronic lymphocytic leukemia cells in vitro.
    Weiler S; Ademokun JA; Norton JD
    Mol Cancer; 2015 Feb; 14(1):30. PubMed ID: 25644253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of early B-cell factor 1 (EBF1) in Hodgkin lymphoma.
    Bohle V; Döring C; Hansmann ML; Küppers R
    Leukemia; 2013 Mar; 27(3):671-9. PubMed ID: 23174882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disruption of the B-cell specific transcriptional program in HHV-8 associated primary effusion lymphoma cell lines.
    Arguello M; Sgarbanti M; Hernandez E; Mamane Y; Sharma S; Servant M; Lin R; Hiscott J
    Oncogene; 2003 Feb; 22(7):964-73. PubMed ID: 12592383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential role of hypoxia in early stages of Hodgkin lymphoma pathogenesis.
    Wein F; Otto T; Lambertz P; Fandrey J; Hansmann ML; Küppers R
    Haematologica; 2015 Oct; 100(10):1320-6. PubMed ID: 26160878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Common features and differences in the transcriptome of large cell anaplastic lymphoma and classical Hodgkin's lymphoma.
    Willenbrock K; Küppers R; Renné C; Brune V; Eckerle S; Weidmann E; Bräuninger A; Hansmann ML
    Haematologica; 2006 May; 91(5):596-604. PubMed ID: 16670065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Global gene expression analysis and novel signalling pathways in Hodgkin lymphoma].
    Bräuninger A; Renné C; Willenbrock K; Martin-Subero JI; Hinsch N; Tiacci E; Siebert R; Küppers R; Hansmann ML
    Verh Dtsch Ges Pathol; 2006; 90():136-41. PubMed ID: 17867590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased ID2 levels in adult precursor B cells as compared with children is associated with impaired Ig locus contraction and decreased bone marrow output.
    Jensen K; Rother MB; Brusletto BS; Olstad OK; Dalsbotten Aass HC; van Zelm MC; Kierulf P; Gautvik KM
    J Immunol; 2013 Aug; 191(3):1210-9. PubMed ID: 23825313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Id2-mediated inhibition of E2A represses memory CD8+ T cell differentiation.
    Masson F; Minnich M; Olshansky M; Bilic I; Mount AM; Kallies A; Speed TP; Busslinger M; Nutt SL; Belz GT
    J Immunol; 2013 May; 190(9):4585-94. PubMed ID: 23536629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PAX5 overexpression is not enough to reestablish the mature B-cell phenotype in classical Hodgkin lymphoma.
    Dimitrova L; Seitz V; Hecht J; Lenze D; Hansen P; Szczepanowski M; Ma L; Oker E; Sommerfeld A; Jundt F; Klapper W; Hummel M
    Leukemia; 2014 Jan; 28(1):213-6. PubMed ID: 23842424
    [No Abstract]   [Full Text] [Related]  

  • 19. Loss of B cell identity correlates with loss of B cell-specific transcription factors in Hodgkin/Reed-Sternberg cells of classical Hodgkin lymphoma.
    Hertel CB; Zhou XG; Hamilton-Dutoit SJ; Junker S
    Oncogene; 2002 Jul; 21(32):4908-20. PubMed ID: 12118370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple isoforms of PAX5 are expressed in both lymphomas and normal B-cells.
    Arseneau JR; Laflamme M; Lewis SM; Maïcas E; Ouellette RJ
    Br J Haematol; 2009 Nov; 147(3):328-38. PubMed ID: 19725825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.